(Q24244034)

English

Lithium for schizophrenia

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Lithium for schizophrenia (English)

0 references

0 references

Werner Kissling

2

0 references

1

0 references

John J. McGrath

3

object named as

John McGrath

0 references

publication date

18 July 2007

0 references

Cochrane Database of Systematic Reviews

0 references

Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Trials of Lithium, Chlorpromazine and Amitriptyline in Schizoaffective Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium carbonate in chronic schizophrenia ? a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Pharmacotherapy of impaired affect in recovering schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

The Northwick Park "functional" psychosis study: diagnosis and treatment response.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A Controlled Study of Lithium vs. Chlorpromazine in Acute Schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium addition to neuroleptic treatment in chronic schizophrenia: a randomized, double-blind, placebo-controlled, cross-over study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Antipsychotic effects of lithium in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Synergism of combined lithium-neuroleptic therapy: a double-blind, placebo-controlled case study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium treatment of psychotic children and adolescents. A controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium combined with haloperidol in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Target symptoms in lithium carbonate therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

The treatment of manic psychoses by the administration of lithium salts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

The effectiveness of lithium in affective and schizo-affective psychoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

d-Amphetamine raises serum prolactin in man: Evaluations after chronic placebo, lithium and pimozide treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Antipsychotic drugs, lithium, carbamazepine, and abnormal diurnal weight gain in psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A Checklist for the Diagnosis of Schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Valproate for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

The mania rating scale: scale construction and inter-observer agreement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Statistics notes. Trials randomised in clusters

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

The unit of analysis error in studies about physicians' patient care behavior

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A standardized psychiatric assessment scale for rating chronic psychotic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Carbamazepine for schizophrenia and schizoaffective psychoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Electroconvulsive therapy for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Benzodiazepines for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Clozapine versus typical neuroleptic medication for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Dropout rates in randomised antipsychotic drug trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

21 January 2018

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The phenomenology of mania. A new look at some old patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward the validation of RDC schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium and haloperidol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlates of lithium response in psychotic-affective syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium and chlorpromazine in psychotic inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium response and psychoses: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium and lecithin in tardive dyskinesia: an update

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A pharmacogenetic case report: lithium-responsive postpsychotic antisocial behavior

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of lithium treatment in established tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychological test for psychopathology.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Manic-Depressive Illness and Acute Schizophrenia: A Clinical, Family History, and Treatment-Response Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

"Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Physostigmine and lithium response in the schizophrenias

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of response to lithium in patients with psychoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of carbamazepine in acute psychosis: a controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjunctive carbamazepine or lithium carbonate in therapy-resistant chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of serum levels of two sustained- release preparations of lithium carbonate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Further Report on Prophylactic Lithium in Recurrent Affective Disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium treatment in post-psychotic depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of lithium therapy on core psychotic symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003834.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD003834.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24244034&oldid=1475278535"